TrianglePUBLICATIONS · 39761483
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2025 Apr
- First author
- Sands J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Sands J
- type
- Author
- name
- Ahn MJ
- type
- Author
- name
- Lisberg A
- type
- Author
- name
- Cho BC
- type
- Author
- name
- Blumenschein G Jr
- type
- Author
- name
- Shum E
- type
- Author
- name
- Pons Tostivint E
- type
- Author
- name
- Goto Y
- type
- Author
- name
- Yoh K
- type
- Author
- name
- Heist R
- type
- Author
- name
- Shimizu J
- type
- Author
- name
- Lee JS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Sands J
- type
- Author
- name
- Ahn MJ
- type
- Author
- name
- Lisberg A
- type
- Author
- name
- Cho BC
- type
- Author
- name
- Blumenschein G Jr
- type
- Author
- name
- Shum E
- type
- Author
- name
- Pons Tostivint E
- type
- Author
- name
- Goto Y
- type
- Author
- name
- Yoh K
- type
- Author
- name
- Heist R
- type
- Author
- name
- Shimizu J
- type
- Author
- name
- Lee JS
- type
- Author
- bibliography ids
- nci-bib-530a15ea9c603586fed96430
- book metadata
- content sha256
- 6dfcc231c90fd9f7ddb17f8f246dd56ed6f479033de3c024343866a293a97808
- document type
- citation
- dois
- 10.1200/JCO-24-01349
- electronic publication date
- display
- 2025 Jan 6
- precision
- day
- year
- 2025
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:39761483
- immutable id
- pubmed:39761483@6dfcc231c90fd9f7ddb17f8f246dd56ed6f479033de3c024343866a293a97808
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 10
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1254-1265
- volume
- 43
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 39761483
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- 2151807e49245455a2c9f663c6516856ca08741b991ca49d87a0a0bb1c290f59
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2025 Apr
- precision
- month
- year
- 2025
- publication types
- Journal Article
- Clinical Trial, Phase II
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.
Preserved source evidence · Not medical advice